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E-mail: gilbert.greub@chuv.chIntroductionIn 2010, approximately 15 million babies were born preterm
worldwide, and more than one million died due to complica-
tions from preterm births (PTB). Neonates that survive PTB
exhibit an increased risk of neurodevelopmental impairments
and respiratory complications [1]. The proportion of sponta-
neous PTB attributed to infection is approximately 50% [2].
However, a pathogen is identiﬁed in only one third of the cases,
despite evidence of infection. Obligate intracellular bacteria,
which do not grow on media used routinely to isolate human
pathogens from clinical samples, might represent possible
agents of PTB.
Chlamydia trachomatis, an obligate intracellular bacterium, is
considered the world’s most common sexually transmitted
bacterial pathogen. Waddlia chondrophila is another member of
the Chlamydiales order that has been shown to cause abortions
in bovines [3]. Both of these intracellular bacteria have alsoNew Microbes and New Infections © 2014 The Authors. Published by Els
This is an open access artibeen implicated in human adverse pregnancy outcomes [4–7].
In addition, C. trachomatis is known to cause premature rupture
of the membranes and premature uterine activity, and growing
evidence suggests a role for C. trachomatis in PTB [8]. In this
study, we investigated the role of Waddlia and Chlamydia as
emerging agents of PTB. We studied 407 women with PTBs or
uneventful term pregnancies attending the University Hospital
of Lausanne, Lausanne, Switzerland. In addition to serology, we
also performed PCR to detect Waddlia and Chlamydia in the
placenta and vaginal samples taken from these women, as well
as histology on the placenta.
From 2006 to 2009, 407 women were enrolled into this
study at the obstetrical ward of the University Hospital of Lau-
sanne. The PTB group (n = 146) included women who sponta-
neously delivered before 37 weeks’ gestation. The control group
(n = 261) included women attending a labour ward with un-
eventful term pregnancies and no history of miscarriages, still-
births or preterm labour. We compared demographic data and
risk factors of patients with and without PTB or C. trachomatis
infection by the Pearson χ2 test (or the Fisher exact test when
indicated) for categorical variables. For continuous variables,
medians were compared by the Wilcoxon-Mann-Whitney test.
Multivariable analyses were performed to control for covariates.
Statistical analyses were performed using the Stata software,
version 13.0 (StataCorp, College Station, TX, USA).New Microbe and New Infect 2015; 3: 41–45
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were signiﬁcantly different between control and PTB groups
(Table 1). Other infectious causes were investigated in the PTB
group, showing that a positive culture was found in the vagina,
maternal or fetal side of the placenta in 32%, 37% and 17% of
the PTB patients, respectively (Supplementary Table 1). Among
all these bacterial species, genital mycoplasma and Gardnerella
vaginalis, which have been previously associated with PTB [9],
were recovered in some subjects from the vagina only (n = 25
and 3, respectively), never from the placenta.
Sera were tested for antibodies directed against
C. trachomatis and W. chondrophila, respectively, by using the
MOMP-R, CT pELISA (R-biopharm, Darmstadt, Germany) [10]
and Waddlia-speciﬁc immunoﬂuorescence as describedTABLE 1. Characteristics of patients according to termhistory
Characteristic
Control
(n [ 261)
PTB
(n [ 146) p
Gestational age at birth,
weeks, ±SD
39.6 ± 1.1 32.6 ± 3.3 <0.001
Age, years, ±SD 31.5 ± 5.0 32.4 ± 5.9 0.057
<35 years 194 (74.3%) 94 (64.4%) 0.041
35 years 67 (25.7%) 52 (35.6%)
Parity, ±SD 0.5 ± 0.8 0.5 ± 0.8 0.950
0 160 (61.3%) 95 (65.1%) 0.228
1 72 (27.6%) 30 (20.6%)
>1 29 (11.1%) 21 (14.4%)
Origin
European 217 (83.1%) 113 (77.4%) 0.156
Non-European 44 (16.9%) 33 (22.6%)
Civil status
Married 201 (77.0%) 109 (74.7%) 0.739
Single 49 (18.8%) 32 (21.9%)
Divorced 11 (4.2%) 5 (3.4%)
Education
Nonuniversity studies 170 (65.1%) 106 (72.6%) 0.150
University studies 91 (34.9%) 40 (27.4%)
No. of lifelong sexual partners
1 58 (22.2%) 37 (25.3%) 0.393
2–3 43 (16.5%) 29 (19.9%)
4–6 45 (17.2%) 19 (13.0%)
>6 36 (13.8%) 13 (8.9%)
Not answered 79 (30.3%) 48 (32.9%)
Condom as previous
contraceptive method
69 (26.4%) 33 (22.6%) 0.407
Smoking status
Nonsmoker 224 (85.8%) 129 (88.4%) 0.543
Smoker 37 (14.2%) 17 (11.6%)
Pets at home 82 (31.4%) 39 (26.7%) 0.366
Vegetarian 5 (1.9%) 5 (3.4%) 0.341
Chlamydia trachomatis serology
IgG positive 19 (7.3%) 13 (8.9%) 0.569
IgA positive 10 (3.8%) 9 (6.2%) 0.330
Both IgG and IgA positive 7 (2.7%) 7 (4.8%) 0.270
C. trachomatis PCR
Cervicovaginal swab 2 (0.7%) 7 (4.8%) 0.012
Placenta 2 (0.7%) 7 (4.8%) 0.012
At least one PCR positive 2 (0.7%) 9 (6.2%) 0.002
Waddlia serology
Total Ig 1/64 47 (18.0%) 31 (21.2%) 0.428
IgG 1/64 38 (14.6%) 22 (15.1%) 0.889
IgM 1/16 9 (3.5%) 11 (7.5%) 0.092
Waddlia PCR
Cervico-vaginal swab 11 (4.2%) 10 (6.9%) 0.252
Placenta 11 (4.2%) 4 (2.7%) 0.587
Other infections
Positive urine culture 7 (2.7%) 38 (26%) <0.001
Streptococcus agalactiae 45 (18.0%) 22 (17.5%) 1.000
Brucella abortus 19 (7.3%) 11 (7.5%) 1.000
Parachlamydia acanthamoebae 2 (0.8%) 0 (0%) 0.539
Simkania negevensis 3 (1.2%) 1 (0.7%) 1.000
PTB, preterm birth.
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Brieﬂy, W. chondrophila strain ATCC VR-1470 was used as
antigen, whereas Fluoline G or M (bioMérieux, Marcy l’Étoile,
France) were used as secondary antibodies. An antibody titre of
1/64 for IgG and 1/32 for IgM were considered as positive,
respectively [6]. There was no difference between control and
PTB groups in terms of anti-Chlamydia IgG and IgA and anti-
Waddlia IgG and IgM titres (Table 1). A total of 54 patients
tested positive only for Waddlia IgG and 26 only for Chlamydia
IgG, indicating the absence of serologic cross-reaction between
both pathogens. Only six patients tested positive for both
Waddlia and Chlamydia IgG (p 0.446).
C. trachomatis IgG seropositivity (Table 2) was associated with
civil status (divorced vs. married, odds ratio (OR) 7.85; 95%
conﬁdence interval (CI) 2.61–23.62), education (OR 0.28; 95%
CI 0.10–0.81) and number of previous sexual partners (>6 vs. 1:
OR 13.12, 95% CI 1.53–112.32; “not answered” vs. 1: OR 13.55,
95% CI 1.76–104.09). Patients who used condoms as a previous
contraceptive method show less C. trachomatis positive serol-
ogies, although this was not statistically signiﬁcant. Of note, only
six (55%) and one (9%) of the 11 patients positive for
C. trachomatis DNA were also positive for C. trachomatis IgG and
IgA, respectively. However, C. trachomatis IgG-positive patients
exhibited signiﬁcantly more histologic chorioamnionitis (50%)
than C. trachomatis IgG-negative patients (28.3%, p 0.015).TABLE 2. Characteristics of patients according to Chlamydia
trachomatis serologic status
Characteristic
IgG negative
(n [ 375, 92.1%)
IgG positive
(n [ 32, 7.9%) p
Age, years, ±SD 31.9 ± 5.3 30.9 ± 6.5 0.298
<35 years 263 (91.3%) 25 (8.7%) 0.421
35 years 112 (94.1%) 7 (5.9%)
Parity, ±SD 0.5 ± 0.8 0.5 ± 0.7 0.997
0 233 (91.4%) 22 (8.6%) 0.38
1 97 (95.1%) 5 (4.9%)
>1 45 (90%) 5 (10.0%)
Origin
European 307 (93.0%) 23 (7.0%) 0.164
Non-European 68 (88.3%) 9 (11.7%)
Civil status
Married 288 (92.9%) 22 (7.1%) >0.001
Single 77 (95.1%) 4 (4.9%)
Divorced 10 (62.5%) 6 (37.5%)
Education
Nonuniversity studies 248 (89.9%) 28 (10.1%) 0.017
University studies 127 (97.0%) 4 (3.1%)
No. of lifelong sexual partners
1 94 (99.0%) 1 (1.0%) 0.006
2–3 66 (91.7%) 6 (8.3%)
4–6 61 (95.3%) 3 (4.7%)
>6 43 (87.8%) 6 (12.2%)
Not answered 111 (87.4%) 16 (12.6%)
Place of residence
Rural 126 (91.3%) 12 (8.7%) 0.699
City 249 (92.6%) 20 (7.4%)
Condom as previous contraceptive method
No 277 (90.8%) 28 (9.2%) 0.094
Yes 98 (96.1%) 4 (3.9%)
Smoking status
Nonsmoker 209 (95.0%) 11 (5.0%) 0.114
Smoker 48 (88.9%) 6 (11.1%)
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FIG. 1. Stepwise logistic regression showing independent association of
positive Chlamydia trachomatis PCR with preterm birth.
NMNI Baud et al. Bovine W. chondrophila and C. trachomatis 43Waddlia seropositivity was not associated with age, number of
lifelong sexual partners, place of residence (rural vs. urban),
smoking, pet ownership or meat consumption (data not shown).
Interestingly, 4.9% of women of European heritage vs. 14.3% of
those of non-European heritage had positive Waddlia IgG se-
rologies of1/256 (p 0.008). This correlation was also observed
for Waddlia IgM of 1/32 (3.6% of European vs. 10.4% of non-
European, p 0.034). Among non-European women, the highest
Waddlia IgG titres (1/128 or 1/256) were more frequent for
black ethnicity (20% and 14.3%, respectively). When total
immunoglobulin (Ig 1/64) against Waddlia was considered,
condoms as a previous contraceptive method protected againstTABLE 3. Clinical history, serology, PCR and placental histolog
real-time PCR
Patient
no.
Maternal
age, years
No.
pregnancies Parity
Gestational
age at birth,
weeks
Birth
weight, g
Countr
of
origin
17 37 2 0 35.3 2520 Switzerl
28 35 10 4 31.5 1870 Angola
45 27 1 0 34.1 2340 Switzerl
66 29 1 0 25.6 890 Portugal
133 40 2 1 30.5 1270 Togo
185 33 2 0 35.1 2060 Switzerl
223 32 2 0 36.3 2370 Portugal
261 39 4 0 34.4 2540 Italy
283 34 4 1 36.4 2560 Congo
314 36 1 0 31.3 1310 Switzerl
351 33 2 0 35.3 2280 Italy
476 35 2 1 30 1530 Italy
572 26 1 0 35 1920 Switzerl
Haematoxylin and eosin–stained histologic sections of all placenta specimens were examine
pedopathologist.
P, placenta; VS, vaginal swab; U, urine; CT, C. trachomatis.
aAll patients were also tested for C. trachomatis, Brucella abortus, Streptococcus agalactiae, Para
bPositive serology for C. trachomatis observed in this case reﬂects a possible coinfection bec
chondrophila, and because the W. chondrophila serology was negative.
cC. trachomatis positive PCR reﬂects a likely coinfection because there is no cross-ampliﬁcat
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condom users exhibited anti-Waddlia Ig reactivity, p 0.041).
After DNA extraction with QIAamp DNA Mini Kit (Qiagen,
Hilden, Germany), all vaginal swabs and placenta samples were
screened for C. trachomatis DNA by a TaqMan real-time PCR
targeting the cryptic plasmid of C. trachomatis, as described
earlier [11]. Samples were also tested by a 16S rRNA Waddlia-
speciﬁc real-time PCR, as described previously [12]. No PCR
inhibition was observed for either pathogen. Vaginal and
placental samples from the PTB group were signiﬁcantly more
often C. trachomatis DNA positive than the control group (p
0.002, unadjusted OR 8.51; 95% CI 1.81–39.93). This associa-
tion reminded signiﬁcant even after adjustment for maternal
age, origin, civil status, education, number of sexual partners
and positive urine cultures (OR 7.93; 95% CI 1.34–46.76).
Stepwise logistic regression allowed us to conﬁrm that the
presence of C. trachomatis DNA is an independent factor
associated with PTB (Fig. 1). There was no difference between
the control and PTB groups regarding Waddlia PCR results.
Thirty-four patients were positive only for W. chondrophila,
whereas ten other subjects were positive only for C. trachomatis
by PCR. Only one patient was positive for both, demonstrating
the absence of cross-ampliﬁcation of these two obligate intra-
cellular bacteria. Presence of Waddlia DNA was demonstrated
in the genital tract or placenta of 13 PTB subjects (Table 3).
Seven of them had more than one miscarriage in their medical
history. Of these 13 patients, four exhibited both a positivey of preterm patients with samples positive for Waddlia by
y
Waddlia
Placental histology
Other
possible
etiologiesaIgG IgM
PCR
positive
and — — P Calciﬁcations
— — P and VS Subchorial ﬁbrin, necrosis,
lymphocytes in chorion and
amnion, vasculitis
and — — VS —
— — VS Subchorial ﬁbrin, lymphocytes
in chorion and amnion,
oedema
1/128 — VS Villous oedema
and — — VS Villous oedema
— — VS — CT IgG and
IgA positiveb
1/128 — P Decidual ﬁbrin
1/256 — VS Subchorial ﬁbrin
and — — VS —
1/128 1/32 VS Marginal hemorrhage
— — VS Lymphocytes in decidua
and — — P and U Intervillous hemorrhage CT PCR
positive
placentac
d for the type and degree of placentitis, endometritis and/or vasculitis by a
chlamydia acanthamoebae and Simkania negevensis.
ause there is no serologic cross-reaction between C. trachomatis and Waddlia
ion with the PCRs we used.
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presence of Waddlia in multiple samples, including vaginal swab,
urine and placenta. Only two of these 13 patients had either a
positive C. trachomatis serology or PCR. Ten of these 13 pa-
tients had abnormal placenta histologies.DiscussionBoth C. trachomatis and W. chondrophila have been implicated in
adverse pregnancy outcomes [4,5,7,8]. However, there have
been contradictory ﬁndings pertaining to the role of
C. trachomatis infection in PTB. A few small studies have failed to
demonstrate a risk of PTB associated with C. trachomatis in-
fections [13,14], although several large, well-conducted studies
have supported a role for C. trachomatis in PTB [15–17]. Thus,
in a large study including 4055 subjects, about 15% of PTB was
attributed to C. trachomatis [16].
We have previously conﬁrmed an association between
Waddlia antibodies and human miscarriage and have demon-
strated its presence in placenta and/or genital tract [4–7]. In the
present study, W. chondrophila was not associated with PTB
despite inﬂammation, and abnormal histology of the placenta
was observed among patients infected by Waddlia (positive
PCR). Women of African descent were more likely to have
positive Waddlia serology. Moreover, condom use was
inversely associated with Waddlia seropositivity.
In contrast to Waddlia, presence of Chlamydia DNA in the
genital tract and/or in the placenta was strongly associated with
PTB. However, C. trachomatis seropositivity did not correlate
with PTB, suggesting that acute rather than chronic
C. trachomatis infection is associated with PTB. Interestingly,
these results are opposite to our previous ﬁndings, in which we
demonstrated that both chronic and acute C. trachomatis in-
fections correlate with miscarriages [18]. Our results conﬁrm
those of a population-based prospective study recently pub-
lished in the Generation R cohort in the Netherlands [16]. In
this large study (>4000 pregnant women), Chlamydia DNA was
strongly associated with PTB but not with miscarriage or
perinatal death. Conﬂicting data between Chlamydia DNA,
serology and pregnancy outcomes may reﬂect different path-
ophysiologic mechanisms, in which Chlamydia-induced mis-
carriages are the result of an immunologic process, whereas the
direct impact of the bacteria results in Chlamydia-induced PTB.
A limitation of our study was the absence of investigation of
other infectious etiology of PTB in all patients (PTB and control
subjects). Some pathogens can reach the placenta by hema-
togenous spread or by an ascending route from the cervix.
Among bacterial infections, Ureaplasma urealyticum, Mycoplasma
hominis and bacterial vaginosis have been associated with PTB,New Microbes and New Infections © 2014 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licebut controversies regarding their true role during pregnancy
persist [9,19].
Overall, these results strongly suggest a role of acute
C. trachomatis infection in PTB, and we strongly recommend
systematically testing for C. trachomatis in any woman at risk for
or after preterm delivery.
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